<--- Back to Details
First PageDocument Content
AIDS / HIV / Fred Hutchinson Cancer Research Center / Antiretroviral drug / Zidovudine / National Institute of Allergy and Infectious Diseases / Hematopoietic stem cell transplantation / Long-term nonprogressor / HIV vaccine / Medicine / HIV/AIDS / Health
Date: 2012-10-08 18:30:32
AIDS
HIV
Fred Hutchinson Cancer Research Center
Antiretroviral drug
Zidovudine
National Institute of Allergy and Infectious Diseases
Hematopoietic stem cell transplantation
Long-term nonprogressor
HIV vaccine
Medicine
HIV/AIDS
Health

DefeatHIV logo sketch v3 gray

Add to Reading List

Source URL: defeathiv.org

Download Document from Source Website

File Size: 1,13 MB

Share Document on Facebook

Similar Documents

Research Associate in HIV Vaccinology funded by the Gates Foundation T cell inducing vaccine for HIV ref. W1/MCEID

DocID: 1vlag - View Document

Research Associate in HIV Vaccinology funded by the Gates Foundation DC targeted ’stealth’ vaccine for HIV ref. W1/MCEID

DocID: 1v243 - View Document

Progress Toward an HIV Vaccine

DocID: 1utfo - View Document

Invitation to become an affiliated member EUROPRISE aims to bring together EU scientists from both microbicide and vaccine fields to embrace a coordinated approach to HIV-1 prevention research. The consortium already com

DocID: 1ui4y - View Document

A. SPECIFIC AIMS. Several lines of evidence implicate CD8+ T cells in control of HIV/SIV replication. In light of the failed Merck STEP vaccine trial, it is arguably more important than ever to understand the attributes

DocID: 1srlm - View Document